News

CardioKinetix, Parachute, PARACHUTE III, heart failure, clinical trial

CardioKinetix Inc. announced results of a pooled analysis study of the catheter-based Parachute ventricular partitioning device. Twelve-month clinical data from PARACHUTE III, a study of 100...

Biotronik announced the publication of new findings from the REPLACE Registry in Circulation: Arrhythmia and Electrophysiology. The Biotronik-sponsored REPLACE Registry...

Discussions regarding late-breaking cardiovascular clinical trials among leading medical scientists are placing considerable emphasis on individualized patient care, particularly in the area of...

A study that identifies new heart attack risk factors and supports the use of a blood test for detection in patients will be published in the AACE (American Association of Clinical...

InspireMD, MGuard, CGuard, drug-eluting stent, MASTER II, CARENET, trials

InspireMD, Inc. announced results from two important clinical trials. Thirty-day results from the MASTER II trial, which enrolled 310 of a planned 1,114 patients were presented at a major...

REPRISE II trial, Lotus Valve System, Boston Scientific, one year data

New data from the Boston Scientific clinical trial program of the Lotus Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic...

Patients who were obese before developing heart failure lived longer than normal weight patients with the same condition according to a new study in the Journal of the American College of...

bioresorbable stents

Ongoing clinical trials of bioresorbable stents continue to show positive data for the devices, which are widely expected to overtake metallic stents in the coming years if the data trend...

stents, bioresorbable, clinical trial, clinical study

Reva Medical initiated patient enrollment with its Fantom bioresorbable drug-eluting scaffold. 

Tiara Transcatheter Mitral Valve, neovasc

Now that transcatheter aortic valve replacement (TAVR) is rapidly becoming an established treatment option, cardiology has shifted focus toward the next major frontier in interventional structural...

The American College of Cardiology and the American Heart Association released clinical data standards for cardiovascular and endpoints in clinical trials.

balloon catheters, clinical trial/study, medtronic, IN.PACT Admiral drug-coated

The results of a landmark study published this month in Circulation indicate that a device from Medtronic Inc. called the IN.PACT Admiral drug-coated balloon (DCB) significantly...

Clinical trial/study, stents, venous therapies

Veniti Inc. announced that it has enrolled the first United States patients in the Virtus trial of the Veniti VICI Venous Stent System.

Cardionovum GmbH announced that it has initiated a 150-patient clinical study of its novel paclitaxel-releasing, high-pressure shunt balloon dilatation catheter, Aperto.

Covidien, Solitaire, stent thrombectomy, trial, Netherlands

In a landmark study evaluating the addition of stent thrombectomy clot removal to pharmaceutical treatment for patients suffering an acute ischemic stroke (AIS), stent thrombectomy provided a...

Data from a Bayer study in children less than 2 years of age (infants) was presented at the 2014 Radiological Society of North America (RSNA) scientific assembly and annual meeting....

Cath lab, clinical trial, clinical study, defibrillator monitors

A faster, coordinated emergency response in collaboration with hospital cardiac catheterization laboratories in each United States region, including New York City, is associated with improving...

Researchers at Okayama University in collaboration with several medical centers in Japan have demonstrated the safety and efficacy of a hypothermal treatment – pharyngeal cooling – for cardiac...

Medtronic, PERIGON Pivotal Trial, pericardial surgical aortic heart valve

Medtronic, Inc. announced it has initiated the PERIGON (PERIcardial SurGical AOrtic Valve ReplacemeNt) Pivotal Trial, a global, prospective clinical trial evaluating an investigational surgical...

Boston Scientific, EVOLVE II, Synergy, bioresorbable stent

In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific Synergy everolimus-eluting bioabsorbable polymer platinum chromium coronary stent system met its...